Denali Therapeutics (DNLI)
(Delayed Data from NSDQ)
$15.43 USD
+0.47 (3.14%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $15.42 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Earnings News For DNLI
-
Why Is Denali Therapeutics (DNLI) Up 2.8% Since Last Earnings Report?
-
Denali's (DNLI) Q4 Earnings Miss, Pipeline in Focus, Stock Up
-
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
-
Why Is Denali Therapeutics Inc. (DNLI) Down 5.2% Since Last Earnings Report?
-
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Lags Revenue Estimates
-
Denali Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
-
Why Is Denali Therapeutics Inc. (DNLI) Down 0.1% Since Last Earnings Report?
-
Denali (DNLI) Q2 Earnings Beat on Higher Collaboration Revenues
-
Denali Therapeutics Inc. (DNLI) Tops Q2 Earnings and Revenue Estimates
-
Denali Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights
-
Why Is Denali Therapeutics Inc. (DNLI) Up 11.9% Since Last Earnings Report?
-
Denali (DNLI) Q1 Earnings Miss Estimates, Pipeline in Focus
-
Denali Therapeutics Inc. (DNLI) Reports Q1 Loss, Tops Revenue Estimates
-
Denali Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights
-
Denali Therapeutics Inc. (DNLI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Why Is Denali Therapeutics Inc. (DNLI) Down 16% Since Last Earnings Report?
-
Denali (DNLI) Q4 Earnings Beat Estimates, Pipeline in Focus
-
Denali Therapeutics Inc. (DNLI) Reports Q4 Loss, Tops Revenue Estimates
-
Denali Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
-
Earnings Preview: Denali Therapeutics Inc. (DNLI) Q4 Earnings Expected to Decline
-
Denali (DNLI) Lags Q3 Earnings Estimates, Pipeline in Focus
-
Denali Therapeutics Inc. (DNLI) Reports Q3 Loss, Lags Revenue Estimates
-
Denali Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
-
Why Is Denali Therapeutics Inc. (DNLI) Down 27.4% Since Last Earnings Report?
-
Denali (DNLI) Q2 Earnings Beat, Pipeline Progress in Focus